---
title: The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
nct_id: NCT02707380
overall_status: COMPLETED
phase: NA
sponsor: NYU Langone Health
study_type: INTERVENTIONAL
primary_condition: Type 2 Diabetes (T2DM)
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02707380.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02707380"
ct_last_update_post_date: 2016-03-31
last_seen_at: "2026-05-12T06:12:56.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

**NCT ID:** [NCT02707380](https://clinicaltrials.gov/study/NCT02707380)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 3
- **Lead Sponsor:** NYU Langone Health
- **Conditions:** Type 2 Diabetes (T2DM), Cardiovascular Disease
- **Start Date:** 2015-03
- **Completion Date:** 2016-03
- **CT.gov Last Update:** 2016-03-31

## Brief Summary

This study is designed to investigate the effect of a structured resistance training program on glycemic control, measured by hemoglobin A1c (glycated hemoglobin), in patients with type 2 diabetes (T2DM) who are enrolled in outpatient cardiac rehabilitation. The investigator will compare the experimental group receiving resistance training to a control group made of patients enrolled in outpatient cardiac rehabilitation and perform 3 aerobic exercise modalities during their sessions, which is the current standard of care.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 85 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Diagnosis with T2DM and have been accepted for a standard outpatient cardiac rehabilitation program
* Cognitively able to comprehend the information presented in the program
* Cognitively able to give informed consent to participate in this study

Exclusion Criteria:

* Patients with orthopedic or neurological limitations that would prevent them from participating in the resistance training program or monitored exercise sessions.
```

## Arms

- **Group 1 Resistance Training Group** (ACTIVE_COMPARATOR) — Participants will perform 3 exercises, one of which will be a series of 7 muscle-strengthening exercises using body weight resistance and elastic resistance bands + 36 sessions of a standard cardiac rehabilitation program consisting of monitored exercise, nutritional guidance, and heart-healthy lifestyle education three times weekly.
- **Group 2 Standard of Care** (ACTIVE_COMPARATOR) — Participants will perform 3 exercises that do not include the 7 muscle-strengthening exercises + 36 sessions of a standard cardiac rehabilitation program consisting of monitored exercise, nutritional guidance, and heart-healthy lifestyle education three times weekly.

## Interventions

- **Resistance Training** (OTHER) — 7 muscle-strengthening exercises using body weight resistance and elastic resistance bands
- **Standard of Care** (OTHER) — 3 exercises that do not include these 7 muscle-strengthening exercises

## Primary Outcomes

- **Comparison of Stress measured by change in heart rate** _(time frame: Baseline, One Year, 2 Years)_
- **Leg strength measured by assessing maximum weight subject can press one time on a leg press machine** _(time frame: up to 2 years)_
- **Paired T-test to compare test-retest Perceived exertion** _(time frame: up to 2 years)_
- **Paired T-test to compare test-retest Perceived dyspnea** _(time frame: up to 2 years)_

## Locations (1)

- New York University School of Medicine, New York, New York, United States

## Recent Field Changes (last 30 days)

- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.new york university school of medicine|new york|new york|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02707380.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02707380*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*